Cargando…

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)

OBJECTIVE: Irritable bowel syndrome with diarrhoea (IBS-D) is a common and challenging condition that significantly reduces quality of life. Enterosgel (polymethylsiloxane polyhydrate) is an intestinal adsorbent which sequesters harmful molecules and is safe and effective in acute infective diarrhoe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, Carol Angela, Kemppinen, Anu, Allgar, Victoria, Dodd, Matthew, Knowles, Charles H, McLaughlin, John, Pandya, Preeti, Whorwell, Peter, Markaryan, Elena, Yiannakou, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Irritable Bowel Syndrome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664110/ https://www.ncbi.nlm.nih.gov/pubmed/35760493 http://dx.doi.org/10.1136/gutjnl-2022-327293

Ejemplares similares

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
por: Kemppinen, Anu, et al.
Publicado: (2020)

A Swedish national adoption study of risk of irritable bowel syndrome (IBS)
por: Waehrens, Rasmus, et al.
Publicado: (2017)

Gut microbiome composition and risk factors in a large cross-sectional IBS cohort
por: Agnello, Melissa, et al.
Publicado: (2020)

Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute
por: Carbone, Florencia, et al.
Publicado: (2022)

Faecal incontinence—the hidden scourge of irritable bowel syndrome: a cross-sectional study
por: Atarodi, Sima, et al.
Publicado: (2015)

Enterosgel for the treatment of adults with acute diarrhoea in a primary care setting: a randomised controlled trial
por: Howell, Carol Angela, et al.
Publicado: (2019)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial
por: Tazzyman, Simon, et al.
Publicado: (2015)

Efficacy of individualised diets in patients with irritable bowel syndrome: a randomised controlled trial
por: Ali, Ather, et al.
Publicado: (2017)

Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial
por: Yan, Ran, et al.
Publicado: (2020)

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet
por: Vervier, Kevin, et al.
Publicado: (2022)

Development of a new version of the Bristol Stool Form Scale: translation, content validity, face validity, and reliability of the Persian version
por: Shokouhi, Nasim, et al.
Publicado: (2022)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
por: Chey, W. D., et al.
Publicado: (2017)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

Enteroadsorbent Polymethylsiloxane Polyhydrate vs. Probiotic Lactobacillus reuteri DSM 17938 in the Treatment of Rotaviral Gastroenteritis in Infants and Toddlers, a Randomized Controlled Trial
por: Markovinović, Leo, et al.
Publicado: (2020)

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
por: Lam, Ching, et al.
Publicado: (2016)

Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs
por: Howell, Carol A., et al.
Publicado: (2019)

Nanostructured Polymethylsiloxane/Fumed Silica Blends
por: Protsak, Iryna, et al.
Publicado: (2019)

Bile acid diarrhoea: pathophysiology, diagnosis and management
por: Farrugia, Alexia, et al.
Publicado: (2020)

Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS
por: Russo, Francesco, et al.
Publicado: (2018)

Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D
por: Emmanuel, Anton, et al.
Publicado: (2020)

Modelling of IBS
por: Zampetakis, Michail
Publicado: (2019)

Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
por: Liu, Tong, et al.
Publicado: (2020)

Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences()
por: Kesuma, Yudianita, et al.
Publicado: (2019)

Modeling IBS and cooling
por: Boine-Frankenheim, Oliver
Publicado: (2010)

IBS spatial resolution
por: Johnson, CD
Publicado: (1972)

TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M
por: Henström, Maria, et al.
Publicado: (2017)

IbOr Regulates Photosynthesis under Heat Stress by Stabilizing IbPsbP in Sweetpotato
por: Kang, Le, et al.
Publicado: (2017)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS
por: Sarvepalli, Sai Suseel, et al.
Publicado: (2023)

Irritable bowel syndrome (IBS) among Lebanese adults: unidentified IBS and associated factors
por: Yazbeck, Gabriella, et al.
Publicado: (2023)

Brain-Gut Interactions in IBS
por: Fichna, Jakub, et al.
Publicado: (2012)

Preparation of SLS for IBS measurements
por: Milas, N, et al.
Publicado: (2012)

Instructions for use of the booster ibs
por: Dorenbos, T, et al.
Publicado: (1973)

I.B.S. vacuum tests
por: Waddup, M G
Publicado: (1972)

The use of RT-PCR for determination of separate end-points for the strains IB H120 and IB D274 in titration of the combination vaccine Poulvac IB(®) primer
por: Geerligs, H.J., et al.
Publicado: (2013)

Biomass acid-catalyzed liquefaction – Catalysts performance and polyhydric alcohol influence
por: Mateus, Maria Margarida, et al.
Publicado: (2015)

Episodic Memories Among Irritable Bowel Syndrome (IBS) Patients: An Important Aspect of the IBS Symptom Experience
por: Sayuk, Gregory S., et al.
Publicado: (2022)

Evaluation of the Birmingham IBS symptom questionnaire
por: Roalfe, Andrea K, et al.
Publicado: (2008)

Proposition de preamplificateur pour IBS
por: Battisti, S
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_oslf42n7hal4abr740urek33ij